22 April 2024 - notice of results
The AIM-listed pharmaceutical group has been forced to delay its annual results' announcement once again as the auditors, Deloitte LLP, have stated that they need more time. This is clearly a concern for investors although the company has confirmed that the details given in the trading update of 29 January remain accurate. Another announcement is expected this Friday, 26 April, with the results now expected to be released in early May. Investors should therefore keep the faith! BUY.
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
